Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q2 EPS of $0.45
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.00 +0.22%
EPS Growth %: +4.8%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: +4.8%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.45, versus $0.41 reported last year. Revenue for the quarter came in at $146.3 million, versus $151.8 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Robinhood prices $2B convertible notes offering due 2029
- AXT appoints Tracy Liu to its board of directors
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
